University Health Network, Toronto: Depression trials
The registry lists 31 Depression studies with University Health Network, Toronto as lead sponsor. 1 are open to participants now and 2 have results posted.
Early Phase 1 1Phase 1 1Phase 2 4Phase 3 7Phase 4 3No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)RecruitingNCT04526093
- 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II DepressionCompletedNCT02363738Phase 2Results posted
- Psychological Support for Patients With an Implantable Cardioverter DefibrillatorCompletedNCT00152763Phase 3Results posted
- Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar DepressionActive, not recruitingNCT06506019Phase 1
- Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of PsilocybinActive, not recruitingNCT06341426Phase 2
- Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT StudyActive, not recruitingNCT05543720Not applicable
- RESTORE in Patients Who Had COVID-19 and Close OthersStatus unknownNCT04958902Not applicable
- Further Development and Initial Testing of RESTORE in Frontline WorkersCompletedNCT04873622Not applicable
- Global CALM Implementation StudyTerminatedNCT04499690
- Treatment of Bipolar Depression With PentoxifyllineCompletedNCT04417049Early Phase 1
- Repetitive Transcranial Magnetic Stimulation Trajectory of Outcomes StudyStatus unknownNCT04376697Not applicable
- Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation StudyCompletedNCT04162522Phase 3
- Dorsomedial rTMS For Depression In Borderline Personality DisorderStatus unknownNCT03472638Not applicable
- Study of Ketamine for Depression in Cancer Patients Receiving Palliative CareCompletedNCT03410446Phase 2
- Examining the Efficacy of Orbitofrontal Cortex rTMS for DepressionCompletedNCT02797210Not applicable
- Comparing Different Patterns of rTMS in Major DepressionStatus unknownNCT02778035Not applicable
- High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Major DepressionStatus unknownNCT02702154Not applicable
- Treating Major Depressive Disorder With Music and Low-frequency Rhythmic Sensory StimulationCompletedNCT02685982Not applicable
- CALM Phase 2b PilotCompletedNCT02353546Not applicable
- The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older AdultsCompletedNCT02228005Phase 4
- Canadian Biomarker Integration Network for Depression StudyCompletedNCT01655706Phase 3
- Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer PatientsCompletedNCT01506492Phase 3
- Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar DepressionCompletedNCT01403662Phase 3
- Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft SurgeryCompletedNCT00622024
- Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive DisorderCompletedNCT00570050Phase 3
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Memory Functioning and Antidepressant TreatmentCompletedNCT00296933Phase 3
- Testosterone and Major DepressionCompletedNCT00286546
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
- Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II DepressionCompletedNCT00188643Phase 4
- Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment ResponseCompletedNCT00188396Not applicable